Clinical Trial

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Name: 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer — clinical trial record (NCT07508852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study aims to investigate and evaluate the safety and performance of a novel probe, PFD3, for the diagnosis and assessment of patients with small cell lung cancer (SCLC).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-27.

Trial Details

NCT Number	NCT07508852
Lead Sponsor	Peking University First Hospital
Conditions	SCLC, SCLC, Extensive Stage, SCLC, Limited Stage, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC )
Enrollment	30 participants
Start Date	2025-10-22
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-18